Mycostatin Related Published Studies
Well-designed clinical trials related to Mycostatin (Nystatin Topical)
Comparison of therapeutic effect of aqueous extract of garlic and nystatin
mouthwash in denture stomatitis. [2012]
Randomised controlled trial of prophylactic fluconazole versus nystatin for the prevention of fungal colonisation and invasive fungal infection in very low birth weight infants. [2011.05]
Oral sustained release nystatin tablets for the treatment of oral candidiasis: formulation development and validation of UV spectrophotometric analytical methodology for content determination. [2010.05]
Comparison of fluconazole and nystatin oral suspensions for prophylaxis of systemic fungal infection in very low birthweight infants. [2010.01]
Effects of nystatin, fluconazole and propolis on poly(methyl methacrylate) resin surface. [2008]
Prevention of fungal peritonitis with nystatin prophylaxis in patients receiving CAPD. [2007.09]
Oral nystatin prophylaxis to prevent invasive candidiasis in Neonatal Intensive Care Unit. [2006.11]
Oral nystatin prophylaxis of Candida spp. colonization in ventilated critically ill patients. [2005.11]
Effect of a buccal bioadhesive nystatin tablet on the lifetime of a Provox silicone tracheoesophageal voice prosthesis. [2005.03]
Well-designed clinical trials possibly related to Mycostatin (Nystatin Topical)
Efficacy and safety of two different antifungal pastes in infants with diaper dermatitis: a randomized, controlled study. [2010.09]
A randomised controlled trial comparing Triadcortyl with 10% glycerine-ichthammol in the initial treatment of severe acute otitis externa. [2008.08]
In vitro and in vivo activity of Melaleuca alternifolia mixed with tissue conditioner on Candida albicans. [2008.03]
Efficacy of enteral decontamination in the prevention of anastomotic dehiscence and pulmonary infection in esophagogastric surgery. [2008]
Elevation of Candida IgG antibodies in patients with medically unexplained symptoms. [2007.12]
The use of topical nonabsorbable gastrointestinal antifungal prophylaxis to prevent fungal infections in critically ill immunocompetent patients: a meta-analysis. [2005.10]
Why do different criteria for 'cure' yield different conclusions in comparing two treatments for bacterial vaginosis? [2005.09]
Other research related to Mycostatin (Nystatin Topical)
[The clinical research of nystatin in prevention of invasive fungal infections in
patients on mechanical ventilation in intensive care unit]. [Article in Chinese] [2013]
Prospective trial finds nystatin mouthwash effective prophylaxis for pulmonary
invasive fungal infections that originate in the throat of patients with
hematologic malignancies. [2013]
Is ototopical nystatin ototoxic? A chinchilla model. [2011.12]
Comparison of therapeutic effect of aqueous extract of garlic and nystatin mouthwash in denture stomatitis. [2011.11.30]
Cutaneous hyalohyphomycosis caused by Paecilomyces lilacinus successfully treated by oral voriconazole and nystatin packing. [2011.08]
Randomised controlled trial of prophylactic fluconazole versus nystatin for the
prevention of fungal colonisation and invasive fungal infection in very low birth
weight infants. [2011]
Enhancement of dissolution of nystatin from buccoadhesive tablets containing various surfactants and a solid dispersion formulation. [2010.11]
Randomised controlled trial of prophylactic fluconazole versus nystatin for the prevention of fungal colonisation and invasive fungal infection in very low birth weight infants. [2010.07.21]
Use of xanthan and its binary blends with synthetic polymers to design controlled release formulations of buccoadhesive nystatin tablets. [2010.07]
Targeted antifungal delivery system: beta-glucosidase sensitive nystatin-star poly(ethylene glycol) conjugate. [2010.02.15]
Synthesis and study of the antifungal activity of new mono- and disubstituted derivatives of a genetically engineered polyene antibiotic 28,29-didehydronystatin A1 (S44HP). [2010.02]
Comparison of fluconazole and nystatin oral suspensions for prophylaxis of
systemic fungal infection in very low birthweight infants. [2010]
Oral nystatin prophylaxis and neonatal fungal infections. [2009.11]
Prophylactic oral nystatin for preterm babies under 33 weeks' gestation decreases fungal colonisation and invasive fungaemia. [2009.07]
Comparison of Fluconazole and Nystatin Oral Suspensions for Prophylaxis of Systemic Fungal Infection in Very Low Birthweight Infants. [2009.06.05]
Development and in vitro evaluation of a mucoadhesive vaginal delivery system for nystatin. [2009.02]
Fungal prophylaxis in very low birth weight neonates: nystatin, fluconazole or nothing? [2008.06]
HPLC method for the determination of nystatin in saliva for application in clinical studies. [2007.11.05]
Quantitative determination of nystatin in human plasma using LC-MS after inhalative administration in healthy subjects. [2006.11.21]
Stability of amphotericin B and nystatin in antifungal mouthrinses containing sodium hydrogen carbonate. [2006.09.26]
Effect of the association of nystatin with a tissue conditioner on its ultimate tensile strength. [2006.09]
Safety, efficacy and pharmacokinetics of tuftsin-loaded nystatin liposomes in murine model. [2006.05]
Enhanced efficacy of pH-sensitive nystatin liposomes against Cryptococcus neoformans in murine model. [2006.02]
["Mixed" and "miscellaneous" vulvovaginitis: diagnostics and therapy of vaginal administration of nystatin and nifuratel] [2005.05]
Potential ototoxicity from triamcinolone, neomycin, gramicidin and nystatin (Tri-Adcortyl) cream. [2005.01]
Other possibly related research studies
Topical voriconazole solution for cutaneous aspergillosis in a pediatric patient after bone marrow transplant. [2006.08]
Great toenail onychomycosis caused by Syncephalastrum racemosum. [2006.01.27]
Survey of topical oral solutions for the treatment of chemo-induced oral mucositis. [2005.12]
Effects of beta-thujaplicin on anti-Malassezia pachydermatis remedy for canine otitis externa. [2005.12]
In vitro susceptibility of oral Candida to seven antifungal agents. [2005.12]
Prednisone-free maintenance immunosuppression-a 5-year experience. [2005.10]
Pharmacological assay of Cordia verbenacea V: oral and topical anti-inflammatory activity, analgesic effect and fetus toxicity of a crude leaf extract. [2005.05]
Safety and success of kidney transplantation and concomitant immunosuppression in HIV-positive patients. [2005.04]
Liposomal polyene antibiotics. [2005]
Study of anticandidal activity of carvacrol and eugenol in vitro and in vivo. [2005.04]
[Use of topical antifungal agents] [2006.05]
Candida-related denture stomatitis: a pilot study of the efficacy of an amorolfine antifungal varnish. [2005.01]
Otomycosis: clinical and mycological study of 97 cases. [2006]
Design of novel antifungal mucoadhesive films Part I. Pre-formulation studies. [2007.02.07]
Observational study of bone-anchored hearing aid infection rates using different post-operative dressings. [2006.10]
Myringoplasty: a comparison of bismuth iodoform paraffin paste gauze pack and tri-adcortyl ointment ear dressing. [2007.04]
Trimethoprim-sulfamethoxazole induced rash and fatal hematologic disorders. [2006.02]
High-dose methylprednisolone influences the physiology and virulence of Candida albicans ambiguously and enhances the candidacidal activity of the polyene antibiotic amphotericin B and the superoxide-generating agent menadione. [2007.03]
Design of novel antifungal mucoadhesive films. Part II. Formulation and in vitro biopharmaceutical evaluation. [2007.05.24]
Effects of solubilizing surfactants and loading of antiviral, antimicrobial, and antifungal drugs on their release rates from ethylene vinyl acetate copolymer. [2007.08]
Oral manifestation of chronic mucocutaneous candidiasis: seven case reports. [2007.10]
[Treatment of fungal infections of upper respiratory tract and ear] [2007]
In vitro susceptibility patterns of fungi associated with keratomycosis in horses of the northeastern United States: 68 cases (1987-2006). [2007.10.01]
Posaconazole for the management of mucosal candidiasis. [2007.06]
An ex-vivo oral mucosa infection model for the evaluation of the topical activity of antifungal agents. [2008.01]
Antifungal prophylaxis for the prevention of neonatal candidiasis? [2008.04]
Cholesterol suppresses cellular TGF-beta responsiveness: implications in atherogenesis. [2007.10.15]
Anti-inflammatory and analgesic activities of the ethanolic extracts from Zanthoxylum riedelianum (Rutaceae) leaves and stem bark. [2007.08]
Denture stomatitis. [2007.03]
Raman, FT-IR, NMR spectroscopic data and antimicrobial activity of bis[micro2-(benzimidazol-2-yl)-2-ethanethiolato-N,S,S-chloro-palladium(II)] dimer, [(micro2-CH2CH2NHNCC6H4)PdCl]2.C2H5OH complex. [2007.08]
Ototopical antifungals and otomycosis: a review. [2008.04]
Oral manifestation of cytomegalovirus associated with herpes simplex virus in renal transplant recipient. [2008.06]
Experience with Alemtuzumab (Campath-1H) as induction agent in renal transplantation followed by steroid-free immunosuppression. [2008.04]
Fulminant septicemia of Bacillus cereus resistant to carbapenem in a patient with biphenotypic acute leukemia. [2008.10]
Local treatment of vulvovaginal candidosis : general and practical considerations. [2008]
Evaluation and treatment of oral candidiasis in HIV/AIDS patients in Enugu, Nigeria. [2008.07]
A selective T-type Ca2+ channel blocker R(-) efonidipine. [2008.06]
Prophylactic oral/topical non-absorbed antifungal agents to prevent invasive fungal infection in very low birth weight infants. [2009.10.07]
Cutaneous fungal infections in the United States: Analysis of the National Ambulatory Medical Care Survey (NAMCS) and National Hospital Ambulatory Medical Care Survey (NHAMCS), 1995-2004. [2009.07]
Superficial distribution and identification of antifungal/antimicrobial agents on a modified tissue conditioner by SEM-EDS microanalysis: a preliminary study. [2009.10]
Harnessing competing endocytic pathways for overcoming the tumor-blood barrier: magnetic resonance imaging and near-infrared imaging of bifunctional contrast media. [2009.07.01]
[Evaluation of susceptibility to antifungal agents of fungal strains isolated from pregnant women with diabetes and healthy pregnant women] [2009.04]
Anti-inflammatory activity of aqueous and alkaline extracts from mushrooms (Agaricus blazei Murill). [2009.04]
Inhibition of Candida albicans biofilm formation on denture material. [2009.05]
Alterations in growth and branching of Neurospora crassa caused by sub-inhibitory concentrations of antifungal agents. [2009.01]
Support for the role of Candida spp. in extensive caries lesions of children. [2009.01]
[A cat with diarrhoea associated with the massive presence of Cyniclomyces guttulatus in the faeces] [2009.03.01]
[Mixed vaginitis prevalence in Latin-American women, according to physician perception. Preference, effectiveness and security of clindamycin plus ketoconazole] [2008.11]
Are topical antimicrobials effective against bacteria that are highly resistant to systemic antibiotics? [2009.01]
Novel mucoadhesive extended release tablets for treatment of oral candidosis: "in vivo" evaluation of the biopharmaceutical performance. [2009.05]
Effect of an antifungal denture liner on the saliva yeast count in patients with denture stomatitis: a pilot study. [2008.09]
Sodium iodide associated to salicylic acid in the topical management of chronic oral candidiasis: a randomized trial. [2010.07]
Fluconazole to prevent systemic fungal infections in infants: reviewing the evidence. [2010.09]
Strategies to prevent invasive candidal infection in extremely preterm infants. [2010.09]
[Local combined therapy of vaginal infections by nifuratel-nistatin] [2010.02]
Current concepts in systemic and topical therapy for superficial mycoses. [2010.03.04]
Candidosis, a new challenge. [2010.03.04]
[Oral candidiasis and dentures] [2010.04]
Prevalence and management of non-albicans vaginal candidiasis. [2010.04]
Oral mucous squamous cell carcinoma-an anticipated consequence of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED). [2010.05]
|